How Veterinary Practices Can Reduce Lab Costs Without Cutting Diagnostics
11 min read
Veterinary practices are under pressure from both sides. Clients are more cost-sensitive, staff time is limited, and routine operating expenses continue to rise. At the same time, doctors still need reliable diagnostics to make confident medical decisions.
The mistake is assuming that lower lab costs require fewer diagnostics.
For most practices, the better path is not cutting coverage. It is improving how diagnostics are ordered, routed, priced, and managed. A practice can often reduce unnecessary lab spend while keeping the same clinical breadth by using the right testing model for the right case.
That means routine, time-sensitive testing should stay fast and accessible. Complex, specialty, pathology-dependent, or low-volume testing should go to the right reference laboratory. Panels should match the medical question. Add-on testing should follow clear criteria. Inventory should be controlled. Missed charges should be found. Turnaround time should be measured.
In other words, lab cost reduction is not a clinical compromise. Done correctly, it is a workflow improvement.
The Real Problem Is Usually Lab Strategy, Not Lab Volume
Many veterinary practices look at their lab bill and assume the issue is overuse. Sometimes that is true. But just as often, the issue is misalignment.
A practice may be sending out routine work that could be handled faster and more efficiently closer to the point of care. Another practice may be running in-house tests that do not have enough volume to justify the equipment, controls, reagents, training, and repeat testing. A third practice may have no clear rule for when a routine result should be escalated to cytology, culture, pathology review, or a larger diagnostic panel.
The result is waste without better medicine.
The goal is not to order fewer diagnostics. The goal is to make every diagnostic step earn its place in the case.
For a general practice, that usually means keeping routine screening accessible while preserving access to broader diagnostic coverage when the case calls for it. CBCs, chemistry panels, urinalysis, fecal testing, cultures, cytology, histopathology, endocrinology, PCR testing, and specialty panels all have a place. A clear test guide makes it easier to see what is available, and the cost problem starts when every case is routed through the same default path.
Start With the Full Cost, Not Just the Invoice Price
Lab costs are easy to underestimate because the invoice only tells part of the story.
A send-out test may look inexpensive on paper, but the true cost includes packaging, pickup timing, accessioning, callbacks, staff handling, follow-up communication, delayed treatment decisions, and sometimes repeat visits. An in-house test may look efficient, but the real cost includes analyzer commitments, controls, calibration, maintenance, staff time, expired reagents, failed quality control, and repeat tests.
A better question is:
What is the landed cost of a reportable, clinically useful result?
That number is more valuable than the price of a single test. It forces the practice to account for hidden waste: redraws, rejected samples, expired kits, rushed shipping, unnecessary add-ons, duplicate testing, and missed billing.
Once the full cost is visible, the right decisions become clearer. Some tests belong in-house. Some belong with a reference lab. Some should only be ordered after a first-line result points in that direction.
Use a Hybrid Model Instead of Choosing One Side
The strongest lab strategy for many practices is a hybrid model.
Point-of-care and in-house testing can be valuable when speed changes the appointment. Sick visits, pre-anesthetic screening, urgent cases, monitoring, and same-day treatment decisions all benefit from fast results. When a doctor can act during the visit, diagnostics become more useful for the patient and easier for the client to understand.
But in-house testing is not automatically better. Some tests need specialist interpretation, more advanced methods, strict quality systems, or broader validation than a clinic can reasonably maintain. Pathology, complex cytology, culture and susceptibility, endocrine workups, PCR panels, official disease testing, and atypical findings often belong with a reference laboratory.
The best model is not "in-house versus send-out." It is:
Run routine, time-sensitive testing where speed matters. Send complex or lower-volume testing where expertise, quality control, and diagnostic depth matter.
That approach protects coverage while reducing waste.
Replace Blanket Panels With Smarter Diagnostic Pathways
One of the fastest ways to reduce lab costs without reducing quality is to stop using broad panels as a default answer to narrow clinical questions.
There are cases where comprehensive testing is absolutely appropriate. A sick patient with vague signs may need broad screening. A senior patient may benefit from a wider view. A complicated case may require multiple systems to be evaluated at once.
But not every case needs the largest available panel.
Practices can reduce waste by building diagnostic pathways around the question being asked. For example, a urinary case may start with urinalysis, then reflex to culture or cytology when specific findings are present. A CBC may be run quickly for routine screening, then escalated for smear review or pathologist input when flags, platelet concerns, atypical cells, or inconsistent findings appear. A respiratory case may not need a broad PCR panel unless the history, exposure risk, severity, or treatment failure justifies it.
This is how practices preserve diagnostic coverage without over-ordering.
The test is still available. It is just used when the case supports it.
Reflex Testing Helps Preserve Coverage While Reducing Waste
Reflex testing is one of the most practical tools for lab cost control.
Instead of ordering every possible test up front, the practice sets criteria for what happens next based on the first result. If the initial finding meets the threshold, the next test is added. If it does not, the patient is spared unnecessary testing and the client is spared unnecessary cost.
Common examples include:
- Urinalysis reflexing to culture when sediment, clinical signs, or collection method supports it.
- CBC abnormalities reflexing to blood smear review or pathologist review.
- Screening chemistry results reflexing to endocrine or organ-specific follow-up.
- Fecal testing reflexing to additional parasite workup when history or findings support it.
The important part is that reflex rules should be written in advance. They should not be random, inconsistent, or purely habit-based. The medical director and clinical leadership should define the criteria, document the workflow, and review the pattern over time.
Good reflex testing does not reduce diagnostic coverage. It makes coverage more precise.
Control Inventory Before Buying More Equipment
A practice can lose a surprising amount of money before a single test is run.
Expired reagents, duplicate stock, emergency orders, poorly tracked controls, and unused supplies all inflate lab costs. This is especially common when lab inventory is split across treatment, pharmacy, exam rooms, and storage areas with no single owner.
Before changing vendors or buying equipment, practices should clean up the basics:
Assign one person to own diagnostic inventory. Set minimum and maximum stock levels. Rotate stock using first-expired, first-out. Track reagents, controls, slides, tubes, strips, stains, and collection supplies separately. Review expired product monthly. Tie ordering to real usage, not habit.
This is not just an accounting exercise. Inventory control protects quality. Expired or poorly stored materials can create unreliable results, repeat testing, and clinical confusion.
Lower waste and better quality often come from the same operational discipline.
Do Not Let Quality Failures Create False Savings
The cheapest lab strategy is not cheaper if it creates repeat testing, unclear results, or delayed decisions.
Veterinary diagnostic quality depends on more than the analyzer. Many errors happen before or after the test itself: sample collection, labeling, storage, transport, timing, processing, interpretation, and communication. A poor sample can make a good test less useful. A delayed specimen can reduce result quality. A result that is not reviewed or explained clearly may not change patient care.
That is why cost reduction has to include quality control.
Practices should track repeat rates, rejected samples, quality-control failures, delayed results, and abnormal-result escalation. If a clinic is running in-house analyzers, staff need documented training, maintenance routines, QC procedures, and clear rules for when to confirm or escalate a result.
Reducing lab costs by weakening quality is a bad trade. Reducing lab costs by preventing repeat work is a good one.
Review Pricing and Charge Capture
Some practices are not losing money because their diagnostics are too expensive. They are losing money because their diagnostic pricing and billing are inconsistent.
Missed charges are common. A technician performs an add-on step. A doctor reviews a smear. A sample is prepared for send-out. A courier or handling fee is absorbed. A repeat is done because the first sample was inadequate. None of it gets reflected in the final invoice.
Over time, that leakage distorts the practice's view of lab profitability.
The answer is not to raise every diagnostic fee blindly. It is to understand the actual cost, the clinical value, and the client communication around each service.
Diagnostics that prevent uncertainty, avoid delays, reduce rechecks, guide treatment, or catch disease earlier have real value. Pricing should reflect that value while still supporting client compliance. If diagnostics feel expensive and poorly explained, clients decline them. If they are clearly tied to better decisions, acceptance improves.
Build a Routing Matrix for Common Tests
A simple routing matrix can help a practice reduce costs quickly.
For each major test family, decide the default path:
- CBC. Which cases stay routine? Which require smear review? Which abnormal flags require escalation?
- Chemistry. Which panels are used for wellness, pre-anesthetic screening, sick visits, and follow-up monitoring?
- Urinalysis. Which cases are handled in-house? When should culture, cytology, or specialist review be added?
- Fecal testing. Which parasite screens are routine? Which require additional send-out methods?
- Culture and susceptibility. When is culture medically indicated? What collection standards are required?
- Cytology and histopathology. Which samples should go directly to pathology review?
- PCR and specialty panels. Which panels require approval or clear criteria before ordering?
This does not need to be complicated. The matrix should fit on one or two internal pages. The value comes from consistency. Once the whole team knows where tests go and why, the practice reduces one-off decisions that create waste.
The Right Reference Lab Can Reduce Cost Without Narrowing Options
For many practices, the reference lab relationship is one of the biggest opportunities for savings.
A national lab may offer broad coverage, but that does not always mean the best total cost, turnaround experience, or support model for every practice. A smaller or regional reference lab can sometimes provide the same diagnostic coverage with more direct communication, more flexible service, and lower monthly spend.
That is where B&L Reference Laboratory fits.
B&L works with veterinary practices that want to reduce lab costs without giving up diagnostic access. Practices can keep the testing they need, maintain reliable workflows, and still evaluate whether their current lab model is costing more than it should.
For many clinics, the opportunity is not one single change. It is a combination of smarter routing, competitive reference lab pricing, practical logistics like local courier pickup and out-of-state shipping, PMS and PIMS integration, and direct human support. Depending on volume, panel mix, and current vendor structure, practices may be able to reduce monthly lab spend meaningfully while keeping diagnostic coverage intact.
A Practical Path Forward
The best way to reduce lab costs is not to start by cutting.
Start by measuring.
Look at the last twelve months of lab spend. Break it down by test family, provider, location, and doctor. Identify the highest-volume tests, the most expensive send-outs, the most common panels, and the tests with frequent repeats or delays. Then ask which costs are medically necessary and which are workflow waste.
From there, build a routing matrix. Add reflex rules. Clean up inventory. Review missed charges. Track turnaround time. Compare your current reference lab pricing and service model against alternatives.
The practices that do this well usually do not become less diagnostic. They become more intentional.
They preserve the tests that matter. They remove waste around the tests. They make faster decisions when speed matters. They use specialist support when complexity matters. And they give clients a clearer reason to say yes to the diagnostics their pets need.
Lower Lab Costs Should Not Mean Lower Standards
Diagnostic coverage is not the enemy of profitability. Poor lab strategy is.
Veterinary practices can reduce lab costs without cutting corners by improving how diagnostics move through the practice: what gets ordered, where it is performed, when it is escalated, how inventory is managed, and how results are communicated.
The goal is simple. Keep the clinical coverage. Remove the waste.
If your practice is reviewing its current lab costs, you can view the test guide, request a shipping label, or Request Info to discuss whether a different reference lab model could lower monthly spend while preserving the diagnostic access your doctors rely on.